Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Washington University School of Medicine
Washington University School of Medicine
Wills Eye
Celgene
University of Washington
OHSU Knight Cancer Institute
Mirna Therapeutics, Inc.
Barbara Ann Karmanos Cancer Institute